BerandaORNBV • HEL
add
Orion Oyj Class B
Tutup sebelumnya
€45,37
Rentang hari
€45,00 - €45,51
Rentang tahun
€31,86 - €50,16
Kapitalisasi pasar
6,45Â M EUR
Volume Rata-Rata
201,86Â rb
Rasio P/E
19,29
Hasil dividen
3,56%
Bursa utama
HEL
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (EUR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 471,30Â jt | 56,53% |
Biaya operasional | 117,40Â jt | 28,73% |
Laba bersih | 160,80Â jt | 161,89% |
Margin laba bersih | 34,12 | 67,34% |
Penghasilan per saham | 1,14 | 159,09% |
EBITDA | 215,00Â jt | 129,70% |
Tarif pajak efektif | 20,20% | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 190,10Â jt | 144,03% |
Total aset | 1,61Â M | 17,17% |
Total liabilitas | 683,30Â jt | 28,51% |
Total ekuitas | 924,40 jt | — |
Saham yang beredar | 140,50 jt | — |
Harga terhadap nilai buku | 6,90 | — |
Tingkat pengembalian aset | 32,95% | — |
Tingkat pengembalian modal | 45,77% | — |
Arus Kas
Perubahan kas bersih
| (EUR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 160,80Â jt | 161,89% |
Kas dari operasi | 67,20Â jt | 103,64% |
Kas dari investasi | -22,10Â jt | 2,64% |
Kas dari pembiayaan | -7,60Â jt | 10,59% |
Perubahan kas bersih | 37,60Â jt | 1.039,39% |
Arus kas bebas | 67,88Â jt | 1.674,51% |
Tentang
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.
Orion's class A and B shares are listed on the Helsinki Stock Exchange. Wikipedia
CEO
Didirikan
1917
Situs
Karyawan
3.867
